Contrave ER 8-90 MG tablet 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F62N2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,806
Award facts
- Contract value 100% obligated
- $12,806.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Contrave ER 8-90 mg tablets (120 count). This competitively awarded, firm fixed-price contract has a ceiling value of $12.8K and an ultimate completion date of December 3, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9M and extending through December 2026, which serves as the primary vehicle for pharmaceutical and medical supply procurement across the Defense Health System.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor for federal medical procurement. The company maintains an extensive portfolio of federal contracts with the DLA, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The Contrave ER tablets being procured under this order are used for weight management and support the military healthcare system's pharmaceutical supply chain requirements. As a primary vendor under the DLA's comprehensive global pharmaceutical support structure, AmerisourceBergen continues to play a vital role in meeting the Defense Department's medical supply needs across military healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26F62N2?
SPE2DR26F62N2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F62N2 worth?
The government has obligated $12,806 on SPE2DR26F62N2.
Is contract SPE2DR26F62N2 an order under another contract?
Yes. SPE2DR26F62N2 is a delivery order under SPE2DR25D3303, an indefinite delivery contract.
Was contract SPE2DR26F62N2 competed?
The extent of competition for SPE2DR26F62N2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award